Literature DB >> 23416239

Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells.

Lianne M Haveman1, Marc Bierings, Mark R Klein, Jeffrey M Beekman, Wilco de Jager, Wietse Kuis, Salvatore Albani, Berent J Prakken.   

Abstract

Adenoviruses (HAdV) can cause life threatening infections, especially in paediatric patients after allogeneic stem cell transplantation (SCT). Yet, no effective antiviral medication is available. One treatment option is adoptive transfer of HAdV-specific T-cells from the graft donor into the patient. Especially CD4+ T-cells are critical to control HAdV infection. To allow for applicability of CD4+ T-cells in adoptive therapy, sufficient numbers of HAdV-specific T-cells with low levels of residual alloreactive T-cells are required. In this study, we explored the possibility to selectively expand and isolate functional HAdV-specific T-cells from PBMCs in response to 15-mer peptides using artificial antigen-presenting cells (aAPCs), composed of liposomes harbouring HAdV-peptide/HLA-Class-II complexes. HAdV-specific T-cells generated using this method produce mainly pro-inflammatory cytokines, express perforin and granzyme B, kill HAdV-infected cells effectively and are not alloreactive. Thus, the generation and isolation of HAdV-specific CD4+ T-cells seem a critical step towards specific adoptive therapy for HAdV infections after allogeneic SCT.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416239     DOI: 10.1016/j.clim.2013.01.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

Review 1.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Nanoengineering approaches to the design of artificial antigen-presenting cells.

Authors:  Joel C Sunshine; Jordan J Green
Journal:  Nanomedicine (Lond)       Date:  2013-07       Impact factor: 5.307

Review 3.  Oncolytic Adenoviruses in Cancer Treatment.

Authors:  Ramon Alemany
Journal:  Biomedicines       Date:  2014-02-21

4.  Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness.

Authors:  Ruilin Zheng; Yinghua Li; Danyang Chen; Jingyao Su; Ning Han; Haitian Chen; Zhihui Ning; Misi Xiao; Mingqi Zhao; Bing Zhu
Journal:  Viruses       Date:  2021-11-28       Impact factor: 5.048

Review 5.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06

Review 6.  Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.

Authors:  Winnie Wy Ip; Waseem Qasim
Journal:  Adv Hematol       Date:  2013-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.